🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Foluso O. Ademuyiwa

James S. McDonnell Foundation

ORCID: 0000-0002-6766-2258

Also affiliated with Washington University in St. Louis

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
6.6Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution

Cell(2020)10.1016/j.cell.2020.03.053
Top 4%
5.6DataRank
Top 4%609 citations

Aviv Regev, Philipp Oberdoerffer, Tal Nawy, Anna Hupalowska, Jennifer E. Rood +92 more

Papers

Driven by 16 papers — median percentile 88. Top paper: “The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution”.

The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution

Cell(2020)10.1016/j.cell.2020.03.053
Top 4%
5.6DataRank
Top 4%609 citations

Aviv Regev, Philipp Oberdoerffer, Tal Nawy, Anna Hupalowska, Jennifer E. Rood +92 more

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0200
N/A
2.5DataRank · unranked
140 citations

Eric J. Jaehnig, Karsten Krug, Jonathan T. Lei, Erik J. Bergstrom, Beom-Jun Kim +34 more

MITI minimum information guidelines for highly multiplexed tissue images

Nature Methods(2022)10.1038/s41592-022-01415-4
N/A
1.7DataRank · unranked
88 citations

Clarence Yapp, Artem Sokolov, Sheila M. Reynolds, Yu-An Chen, Damir Sudar +95 more

Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06307-3
N/A
1.1DataRank · unranked
35 citations

Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann, Bryan Fisk +29 more

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

EBioMedicine(2022)10.1016/j.ebiom.2022.104316
Top 20%
1.0DataRank
Top 20%17 citations

Lorenzo Gerratana, Katherine Clifton, Arielle J. Medford, Marko Velimirovic, Whitney L. Hensing +17 more

Microscaled proteogenomic methods for precision oncology

Nature Communications(2020)10.1038/s41467-020-14381-2
N/A
0.722DataRank · unranked
122 citations

Eric J. Jaehnig, Karsten Krug, Beom‐Jun Kim, Alexander B. Saltzman, Doug W. Chan +28 more

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)

npj Breast Cancer(2023)10.1038/s41523-022-00504-z
N/A
0.705DataRank · unranked
23 citations

Donald W. Northfelt, Tracey L. O’Connor, Ellis Levine, Jingqin Luo, Yu Tao +16 more

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013

npj Breast Cancer(2022)10.1038/s41523-022-00500-3
N/A
0DataRank · unranked
54 citations

Feng Gao, Cherease R. Street, Ina Chen, Donald W. Northfelt, Robert Wesolowski +21 more

Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0501
N/A
0DataRank · unranked
2 citations

Alexander B. Saltzman, Eric J. Jaehnig, Jonathan T. Lei, Anna Malovannaya, Matthew V. Holt +7 more

Data from Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins

(2023)10.1158/2767-9764.c.6752049
N/A
0DataRank · unranked
0 citations

Alexander B. Saltzman, Eric J. Jaehnig, Jonathan T. Lei, Anna Malovannaya, Matthew V. Holt +7 more

Optimal co-clinical radiomics: Sensitivity of radiomic features to tumour volume, image noise and resolution in co-clinical T1-weighted and T2-weighted magnetic resonance imaging

EBioMedicine(2020)10.1016/j.ebiom.2020.102963
N/A
0DataRank · unranked
114 citations

Timothy Whitehead, James D. Quirk, Amber Salter, Foluso O. Ademuyiwa, Shunqiang Li +3 more

Radiologic imaging biomarkers in triple-negative breast cancer: a literature review about the role of artificial intelligence and the way forward

BJR|Artificial Intelligence(2024)10.1093/bjrai/ubae016
N/A
0DataRank · unranked
9 citations

Qi Xiao, José Marcio Luna, Emily Podany, Tabassum Ahmad, Foluso O. Ademuyiwa +4 more

Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy Using Biomarkers, Ultrasound, and Diffuse Optical Tomography

Research Square(2020)10.21203/rs.3.rs-54759/v1
N/A
0DataRank · unranked
2 citations

Foluso O. Ademuyiwa, Catherine Young, Catherine M. Appleton, Matthew F. Covington, X. Cynthia +9 more

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

UNC Libraries(2020)10.17615/01wd-2j16
N/A
0DataRank · unranked
0 citations

Matthias W. Beckmann, Federico Canzian, Dimopoulos, Athanasios M, Leslie Bernstein, Jenny Chang‐Claude +27 more

Molecular characterization of the Ras-MAPK pathway in metastatic breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.1034
N/A
0DataRank · unranked
2 citations

Jun Yin, Joanne Xiu, W. Michael Korn, Heinz‐Josef Lenz, Gino K. In +14 more

Immunogenomic Profiling and Pathological Response Results From a Clinical Trial of Docetaxel and Carboplatin in Triple Negative Breast Cancer

Research Square(2021)10.21203/rs.3.rs-420931/v1
N/A
0DataRank · unranked
1 citations

Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann, Bryan Fisk +29 more